CRN safe nutrient intake
This article was originally published in The Tan Sheet
Executive Summary
Vitamin and Mineral Safety 2nd Edition provides "supportable data" on safe levels of vitamin and mineral intake that is "far preferable" to Recommended Daily Allowances at a time when Codex Alimentarius is debating science-based standards for supplement regulation, the Council for Responsible Nutrition announces July 30. The publication is a quantitative risk assessment meant to "identify the highest chronic supplemental intake of vitamins and minerals that can be confidently asserted to pose no risk for the majority of the normal adult population," according to author John Hathcock, PhD, VP-scientific & international affairs, who also wrote the first edition in 1997 (1"The Tan Sheet" July 28, 1997)...
You may also be interested in...
CRN suggests nutrient "safety approach" based on "no adverse effect level" values.
VITAMIN E "NO OBSERVED ADVERSE EFFECT LEVEL" OF 80 TIMES RDA PROPOSED BY CRN in a July 8 report entitled "Vitamin and Mineral Safety." The Council for Responsible Nutrition asserts in the report its long-held contention that the Recommended Dietary Allowances set forth by the Food & Nutrition Board of the National Academy of Sciences are "not a valid basis for identifying safe upper intakes of vitamins and minerals." The report provides alternative methods for identifying safe upper nutrient intakes based on the use of "No Observed Adverse Effect Level" (NOAEL) and "Lowest Observed Adverse Effect Level" (LOAEL) values for 25 specific nutrients
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.